Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma

被引：31

作者：

Thom, J

Gilmore, G

Yi, Q

Hankey, GJ

Eikelboom, JW

机构：

[1] Royal Perth Hosp, Coagulat Unit, Dept Haematol, Perth, WA 6000, Australia

[2] Princess Margaret Hosp, Dept Biostat, Toronto, ON M4X 1K9, Canada

[3] Royal Perth Hosp, Dept Neurol, Stroke Unit, Perth, WA, Australia

[4] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 11期

关键词：

D O I：

10.1111/j.1538-7836.2004.00962.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2067 / 2069

页数：3

共 6 条

[1] Should soluble CD40 ligand be measured from serum or plasma samples? [J].

Bereczki, D ;

Nagy, E ;

Pál, A ;

Magyar, MT ;

Balla, J .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (06) :1129-1130

[2]

Blake GJ, 2003, ARTERIOSCL THROM VAS, V23, P1130

[3] Soluble P-selectin should be measured in citrated plasma, not in serum [J].

Caine, GJ ;

Blann, AD .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (03) :530-532

[4] Soluble CD40 ligand in acute coronary syndromes [J].

Heeschen, C ;

Dimmeler, S ;

Hamm, CW ;

van den Brand, MJ ;

Boersma, E ;

Zeiher, AM ;

Simoons, ML ;

CAPTURE Study Investigators .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) :1104-1111

[5] Soluble P-selectin and the risk of future cardiovascular events [J].

Ridker, PM ;

Buring, JE ;

Rifai, N .

CIRCULATION, 2001, 103 (04) :491-495

[6] Soluble CD40L and cardiovascular risk in women [J].

Schönbeck, U ;

Varo, N ;

Libby, P ;

Buring, J ;

Ridker, PM .

CIRCULATION, 2001, 104 (19) :2266-2268

← 1 →